PR PolyResearch

Join Free

NASDAQ

Curanex Pharmaceuticals Inc (CURX)

♥ 551 Thanks from members

Curanex Pharmaceuticals Inc (CURX) faces intense market scrutiny, marked by a widening net loss, severe going-concern warnings, pending securities fraud investigations, and a Nasdaq minimum bid price deficiency.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Other Nasdaq Tickers

GraniteShares 2x Long AAPL Daily ETF (AAPB)

Apple Inc. (AAPL)

Direxion Daily AAPL Bear 1X ETF (AAPD)

Ascentage Pharma Group International - American Depository Shares (AAPG)

Direxion Daily AAPL Bull 2X ETF (AAPU)

Rocket Pharmaceuticals, Inc. - Warrant (RCKTW)